| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
CA: A Cancer Journal for Clinicians, Vol 50, Issue 4 215-236, Copyright © 2000 by American Cancer Society
D. S. Rigel and J. A. Carucci
Malignant melanoma continues to present a significant public health problem
as its incidence is rising faster than that of any other cancer in the US.
At current rates, 1 in 74 Americans will develop melanoma during his or her
lifetime. Management of melanoma is a complex issue requiring a
multidisciplinary approach. The most effective method of protection against
the development of melanoma is minimization of ultraviolet exposure from
sunlight. Early detection and treatment are critical and result in improved
patient survival rates. Surgical excision remains the mainstay of treatment
but many new promising therapies are being investigated. It is hoped that
increased public and professional awareness and education in all areas
relating to the prevention, detection, and treatment of malignant melanoma
will contribute to decreasing trends in the incidence and mortality from
this cancer in the future.
ARTICLES
Malignant melanoma: prevention, early detection, and treatment in the 21st century
Ronald O. Perelman Department of Dermatology, New York University Medical School, NY, USA.
This article has been cited by other articles:
|
|
 |
|
  A. L. Olson, C. A. Gaffney, P. Starr, and A. J. Dietrich The impact of an appearance-based educational intervention on adolescent intention to use sunscreen Health Educ. Res., October 1, 2008; 23(5): 763 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. McDermott, J. A. Sosman, R. Gonzalez, F. S. Hodi, G. P. Linette, J. Richards, J. W. Jakub, M. Beeram, S. Tarantolo, S. Agarwala, et al. Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group J. Clin. Oncol., May 1, 2008; 26(13): 2178 - 2185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Scope, S. W. Dusza, A. C. Halpern, H. Rabinovitz, R. P. Braun, I. Zalaudek, G. Argenziano, and A. A. Marghoob The "Ugly Duckling" Sign: Agreement Between Observers Arch Dermatol, January 1, 2008; 144(1): 58 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gallus, L. Naldi, P. Carli, C. La Vecchia, and the Italian Group for Epidemiologic Research in De Nevus Count on Specific Anatomic Sites as a Predictor of Total Body Count: A Survey of 3,406 Children from Italy Am. J. Epidemiol., August 15, 2007; 166(4): 472 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Bradford and P. A. Levine Incidence and Prognosis of Cutaneous Melanoma Involving the Head and Neck JAMA, June 20, 2007; 297(23): 2628 - 2629. [Full Text] [PDF]
|
|
|
|
|
|
A. Scope, M. Gill, C. Benveuto-Andrade, A. C. Halpern, S. Gonzalez, and A. A. Marghoob Correlation of Dermoscopy With In Vivo Reflectance Confocal Microscopy of Streaks in Melanocytic Lesions Arch Dermatol, June 1, 2007; 143(6): 727 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rangel, S. Torabian, L. Shaikh, M. Nosrati, F. L. Baehner, C. Haqq, S. P.L. Leong, J. R. Miller III, R. W. Sagebiel, and M. Kashani-Sabet Prognostic Significance of Nuclear Receptor Coactivator-3 Overexpression in Primary Cutaneous Melanoma J. Clin. Oncol., October 1, 2006; 24(28): 4565 - 4569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Niles, C. P. Cook, G. G. Meadows, Y.-M. Fu, J. L. McLaughlin, and G. O. Rankin Resveratrol Is Rapidly Metabolized in Athymic (Nu/Nu) Mice and Does Not Inhibit Human Melanoma Xenograft Tumor Growth J. Nutr., October 1, 2006; 136(10): 2542 - 2546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-M. Jangi, J. L. Diaz-Perez, B. Ochoa-Lizarralde, I. Martin-Ruiz, A. Asumendi, G. Perez-Yarza, J. Gardeazabal, J. L. Diaz-Ramon, and M. D. Boyano H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells Carcinogenesis, September 1, 2006; 27(9): 1787 - 1796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Grabacka, P. M. Plonka, K. Urbanska, and K. Reiss Peroxisome Proliferator-Activated Receptor {alpha} Activation Decreases Metastatic Potential of Melanoma Cells In vitro via Down-Regulation of Akt. Clin. Cancer Res., May 15, 2006; 12(10): 3028 - 3036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-M. Postovit, E. A. Seftor, R. E.B. Seftor, and M. J.C. Hendrix A Three-Dimensional Model to Study the Epigenetic Effects Induced by the Microenvironment of Human Embryonic Stem Cells Stem Cells, March 1, 2006; 24(3): 501 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Azzarello, S. Dessureault, and P. B. Jacobsen Sun-Protective Behavior among Individuals with a Family History of Melanoma Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 142 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Seftor, K. M. Brown, L. Chin, D. A. Kirschmann, W. W. Wheaton, A. Protopopov, B. Feng, Y. Balagurunathan, J. M. Trent, B. J. Nickoloff, et al. Epigenetic Transdifferentiation of Normal Melanocytes by a Metastatic Melanoma Microenvironment Cancer Res., November 15, 2005; 65(22): 10164 - 10169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Bottoni, P. Bonaccorsi, V. Devirgiliis, V. Panasiti, R. G. Borroni, G. Trasimeni, R. Clerico, and S. Calvieri Complete Remission of Brain Metastases in Three Patients with Stage IV Melanoma Treated with BOLD and G-CSF Jpn. J. Clin. Oncol., September 1, 2005; 35(9): 507 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Cheng, A. Mahmood, H. Li, A. Davison, and A. G. Jones [99mTcOAADT]-(CH2)2-NEt2: A Potential Small-Molecule Single-Photon Emission Computed Tomography Probe for Imaging Metastatic Melanoma Cancer Res., June 15, 2005; 65(12): 4979 - 4986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Lowe, J. Ball, B. M. Lynch, L. Baldwin, M. Janda, W. R. Stanton, and J. F. Aitken Acceptability and feasibility of a community-based screening programme for melanoma in Australia Health Promot. Int., December 1, 2004; 19(4): 437 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Hemmings, D. S. Johnson, G. T. Tominaga, and J. H. Wong Cutaneous Melanoma in a Multiethnic Population: Is This a Different Disease? Arch Surg, September 1, 2004; 139(9): 968 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Takeuchi, D. L. Morton, C. Kuo, R. R. Turner, D. Elashoff, R. Elashoff, B. Taback, A. Fujimoto, and D. S.B. Hoon Prognostic Significance of Molecular Upstaging of Paraffin-Embedded Sentinel Lymph Nodes in Melanoma Patients J. Clin. Oncol., July 1, 2004; 22(13): 2671 - 2680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Aitken, P. H. Youl, M. Janda, M. Elwood, I. T. Ring, J. B. Lowe, and D. W. Firman Validity of Self-reported Skin Screening Histories Am. J. Epidemiol., June 1, 2004; 159(11): 1098 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Elias, K. K. Tanabe, A. J. Sober, M. A. Gadd, M. C. Mihm, B. Goodspeed, and A. B. Cosimi Is Completion Lymphadenectomy After a Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma Always Necessary? Arch Surg, April 1, 2004; 139(4): 400 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Burroni, R. Corona, G. Dell'Eva, F. Sera, R. Bono, P. Puddu, R. Perotti, F. Nobile, L. Andreassi, and P. Rubegni Melanoma Computer-Aided Diagnosis: Reliability and Feasibility Study Clin. Cancer Res., March 15, 2004; 10(6): 1881 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D Baade, K. P Balanda, W. R Stanton, J. B Lowe, and C. B Del Mar Community Perceptions of Specific Skin Features of Possible Melanoma Health Education Journal, January 1, 2004; 63(2): 158 - 169. [Abstract] [PDF]
|
|
|
|
|
|
S. Moredock, R. S. Nairn, D. A. Johnston, M. Byrom, G. Heaton, M. Lowery, and D. L. Mitchell Mechanisms underlying DNA damage resistance in a Xiphophorus melanoma cell line Carcinogenesis, December 1, 2003; 24(12): 1967 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Albert and M. A. Weinstock Keratinocyte Carcinoma CA Cancer J Clin, September 1, 2003; 53(5): 292 - 302. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. P. Dellavalle, L. M. Schilling, A. K. Chen, and E. J. Hester Teenagers in the UV Tanning Booth?: Tax the Tan Arch Pediatr Adolesc Med, September 1, 2003; 157(9): 845 - 846. [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Pockaj, D. E. Jaroszewski, D. J. DiCaudo, J. G. Hentz, E. W. Buchel, R. J. Gray, S. N. Markovic, and U. Bite Changing Surgical Therapy for Melanoma of the External Ear Ann. Surg. Oncol., July 1, 2003; 10(6): 689 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Lowe, E. Hurst, J. F. Moley, and L. A. Cornelius Sentinel Lymph Node Biopsy in Patients With Thin Melanoma Arch Dermatol, May 1, 2003; 139(5): 617 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ng-Cashin, J. J. Kuhns, S. E. Burkett, J. D. Powderly, R. R. Craven, H. W. van Deventer, S. L. Kirby, and J. S. Serody Host Absence of CCR5 Potentiates Dendritic Cell Vaccination J. Immunol., April 15, 2003; 170(8): 4201 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dhawan, A. B. Singh, D. L. Ellis, and A. Richmond Constitutive Activation of Akt/Protein Kinase B in Melanoma Leads to Up-Regulation of Nuclear Factor-{kappa}B and Tumor Progression Cancer Res., December 15, 2002; 62(24): 7335 - 7342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Neef, M. A. Kuske, E. Prols, and J. P. Johnson Identification of the Human PHLDA1/TDAG51 Gene: Down-Regulation in Metastatic Melanoma Contributes to Apoptosis Resistance and Growth Deregulation Cancer Res., October 15, 2002; 62(20): 5920 - 5929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. James, M. K. Tripp, G. S. Parcel, A. Sweeney, and E. R. Gritz Psychosocial correlates of sun-protective practices of preschool staff toward their students Health Educ. Res., June 1, 2002; 17(3): 305 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Krowchuk Sun Protection for Children: What Parents Do AAP Grand Rounds, November 1, 2001; 6(5): 55 - 56. [Full Text] [PDF]
|
|
|
|
|
|
G. Q. Phan, P. Attia, S. M. Steinberg, D. E. White, and S. A. Rosenberg Factors Associated With Response to High-Dose Interleukin-2 in Patients With Metastatic Melanoma J. Clin. Oncol., August 1, 2001; 19(15): 3477 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Anderson, S. R. Baker, L. Lowe, L. Su, and T. M. Johnson Treatment of Head and Neck Melanoma, Lentigo Maligna Subtype: A Practical Surgical Technique Arch Facial Plast Surg, July 1, 2001; 3(3): 202 - 206. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
